All Articles

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

The fight for STAAR Surgical heats up. Alcon's new $1.6B offer isn't enough for its largest shareholder, who alleges a deeply conflicted sales process.

A logistics firm's stock soared 1,100% then collapsed overnight. Inside the alleged pump-and-dump scheme that reveals deep cracks in market integrity.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Rivals like OpenAI, Google, and Microsoft are joining forces under the Linux Foundation to build open standards for autonomous AI. What does this mean?

iDEAL's grip on Dutch iGaming isn't just about payments. Explore how trust, regulation, and tech created a unique digital fortress for online casinos.

Amara Industries' strategic acquisition of Thomson Plastics signals a major shift, creating a tech-forward giant in North American injection molding.

A landmark deal between retail, ad-tech, and media giants aims to build Europe's most advanced data-driven advertising network. What does it mean for brands?

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

Cleric's new AI SRE agent promises to end engineering firefighting by learning from incidents. With $9.8M in funding, is this the future of system reliability?

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

Black Friday’s record-breaking data demands reveal a blueprint for healthcare's own looming data crisis. What can medicine learn from retail's tech engine?

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A new memory module may seem obscure, but it’s a key piece of the puzzle for building trusted AI, resilient 5G, and reliable edge computing.

A new partnership between evermore and Vallarta Supermarkets isn't just about groceries; it's about using tech to deliver health equity with cultural dignity.

Regenerative Patch Technologies advances its stem cell therapy for dry AMD, signaling a potential shift from merely slowing blindness to actively improving vision.

A routine UK disclosure by an investment giant has pulled back the curtain on a major transatlantic auto merger and the silent influence of institutional capital.

Hyatt's new safari partnership isn't just a perk; it's a strategic move into purpose-driven travel, redefining luxury loyalty for a new era.